Why is Nureca falling/rising?

As of 18-Nov, Nureca Ltd's stock price is currently at 266.00, reflecting a decrease of 5.2 points or 1.92%. The stock has been experiencing a downward trend, having fallen for the last two consecutive days with a total decline of 3.1% during this period. Despite the company reporting very positive results, including a significant net profit growth of 348.15% and a rise in promoter confidence with a 0.64% increase in stake, the stock has underperformed against the benchmark indices. Over the past week, Nureca's stock has decreased by 1.77%, while the Sensex has gained 0.96%. Additionally, the stock's liquidity appears to be declining, with a notable drop in delivery volume by 95.18% compared to the five-day average.
In the broader market context, Nureca's performance has been consistently weaker than the benchmark, with a year-to-date return of -5.66% compared to the Sensex's 8.36% gain. The medical equipment sector, in which Nureca operates, has also faced challenges, evidenced by a sector decline of 2.05%. This underperformance is compounded by the company's long-term fundamental weaknesses, including a -143.07% CAGR growth in operating profits over the last five years and a negative EBITDA, which raises concerns about its profitability and future growth potential. Overall, while there are positive indicators such as strong quarterly results and increased promoter confidence, the stock's recent price movement reflects broader market challenges and ongoing investor caution.